Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

« Back

BDSI First Quarter 2019 Financial Results Call and Webcast

May 6, 2019 at 4:30 PM EDT

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon